Loading…
Sanit Technologies, LLC dba Durisan, a drug manufacturer, violated current good manufacturing practice (CGMP) regulations for finished pharmaceuticals during an FDA inspection in March 2021. The company's quality control unit failed to properly oversee batch release and distributed Durisan Hand Sanitizer, Alcohol-Free products that did not meet specifications for microbial contamination, including identification of Burkholderia cepacia (an opportunistic pathogen) in multiple lots released between April and December 2020. These manufacturing and quality control failures rendered the drug products adulterated and unfit for distribution to consumers.